Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study.

Azhar Mahmood Farooqui, Amit Arya, Amit Singh, Pronob Kumar Dalal
{"title":"Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study.","authors":"Azhar Mahmood Farooqui,&nbsp;Amit Arya,&nbsp;Amit Singh,&nbsp;Pronob Kumar Dalal","doi":"10.34172/ahj.2022.1310","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Injecting drug use (IDU) is a growing concern in India. This problem may coexist with other psychiatric disorders. The psychiatric comorbidity in IDUrs affects the psychosocial functioning of this population. This study aimed to assess psychiatric comorbidities, psychosocial problems, and global functioning of people who inject opioids.</p><p><strong>Methods: </strong>This cross-sectional study included opioid-dependent individuals with a history of injecting opioids who visited an outpatient clinic for buprenorphine maintenance treatment. The patients were assessed by SCID-I and SCID-II for Axis-I and Axis-II psychiatric disorders, respectively. The diagnosis was confirmed according to DSM-IV-TR. Moreover, the assessment of psychosocial and environmental problems was done according to Axis-IV of DSM-IV. Functioning was assessed using the Global Assessment of Functioning Scale (GAF). Substance use severity was also assessed using Addiction Severity Index (ASI).</p><p><strong>Findings: </strong>A total of 100 participants were included in the study. All participants were male, and the majority (63%) were in the age range of 18-40 years with the mean age of 36.96 (SD=10.12). Moreover, 76% of the participants had psychiatric comorbidity. Mood disorder (28.95%), anxiety disorder (13.16%), any personality disorder (27.63%) were the most common comorbidities. The results also revealed psychosocial and environmental problems were significantly higher in participants with comorbidity and their global functioning was poor.</p><p><strong>Conclusion: </strong>Psychiatric comorbidities are quite common and are associated with various psychosocial and environmental problems. Early identification and interventions for comorbid conditions along with community-based psychosocial rehabilitation should be considered for better outcomes.</p>","PeriodicalId":33943,"journal":{"name":"Addiction and Health","volume":"14 3","pages":"218-223"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/24/ahj-14-218.PMC9743822.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction and Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/ahj.2022.1310","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Injecting drug use (IDU) is a growing concern in India. This problem may coexist with other psychiatric disorders. The psychiatric comorbidity in IDUrs affects the psychosocial functioning of this population. This study aimed to assess psychiatric comorbidities, psychosocial problems, and global functioning of people who inject opioids.

Methods: This cross-sectional study included opioid-dependent individuals with a history of injecting opioids who visited an outpatient clinic for buprenorphine maintenance treatment. The patients were assessed by SCID-I and SCID-II for Axis-I and Axis-II psychiatric disorders, respectively. The diagnosis was confirmed according to DSM-IV-TR. Moreover, the assessment of psychosocial and environmental problems was done according to Axis-IV of DSM-IV. Functioning was assessed using the Global Assessment of Functioning Scale (GAF). Substance use severity was also assessed using Addiction Severity Index (ASI).

Findings: A total of 100 participants were included in the study. All participants were male, and the majority (63%) were in the age range of 18-40 years with the mean age of 36.96 (SD=10.12). Moreover, 76% of the participants had psychiatric comorbidity. Mood disorder (28.95%), anxiety disorder (13.16%), any personality disorder (27.63%) were the most common comorbidities. The results also revealed psychosocial and environmental problems were significantly higher in participants with comorbidity and their global functioning was poor.

Conclusion: Psychiatric comorbidities are quite common and are associated with various psychosocial and environmental problems. Early identification and interventions for comorbid conditions along with community-based psychosocial rehabilitation should be considered for better outcomes.

Abstract Image

注射阿片类药物的人的精神共病、社会心理问题和功能:一项观察性研究。
背景:注射吸毒(IDU)在印度日益受到关注。这个问题可能与其他精神障碍并存。idur患者的精神合并症影响了这一人群的社会心理功能。本研究旨在评估注射阿片类药物的人的精神合并症、社会心理问题和整体功能。方法:本横断面研究纳入了有阿片类药物注射史的阿片类药物依赖者,他们曾到门诊接受丁丙诺啡维持治疗。分别用scid - 1和SCID-II对患者进行轴i和轴ii精神障碍的评估。根据DSM-IV-TR确诊。此外,根据DSM-IV的Axis-IV进行心理社会和环境问题的评估。使用功能总体评估量表(GAF)评估功能。使用成瘾严重程度指数(ASI)评估药物使用严重程度。研究结果:共纳入100名参与者。所有参与者均为男性,大多数(63%)年龄在18-40岁之间,平均年龄36.96岁(SD=10.12)。此外,76%的参与者有精神疾病。情绪障碍(28.95%)、焦虑障碍(13.16%)、任何人格障碍(27.63%)是最常见的合并症。结果还显示,有共病的参与者的社会心理和环境问题明显更高,他们的整体功能较差。结论:精神合并症相当普遍,并与各种社会心理和环境问题有关。为了获得更好的结果,应考虑对合并症进行早期识别和干预,同时进行以社区为基础的社会心理康复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
3
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信